nodes	percent_of_prediction	percent_of_DWPC	metapath
Epirubicin—bone cancer—ocular cancer	0.301	0.41	CtDrD
Epirubicin—peripheral nervous system neoplasm—ocular cancer	0.221	0.3	CtDrD
Epirubicin—sarcoma—ocular cancer	0.212	0.289	CtDrD
Epirubicin—ABCC1—Dactinomycin—ocular cancer	0.131	1	CbGbCtD
Epirubicin—Radiation injury—Dactinomycin—ocular cancer	0.00428	0.109	CcSEcCtD
Epirubicin—Radiation recall reaction (dermatologic)—Dactinomycin—ocular cancer	0.00274	0.0697	CcSEcCtD
Epirubicin—Recall phenomenon—Dactinomycin—ocular cancer	0.00259	0.066	CcSEcCtD
Epirubicin—Neutropenic sepsis—Dactinomycin—ocular cancer	0.00259	0.066	CcSEcCtD
Epirubicin—Venous thrombosis—Carboplatin—ocular cancer	0.00224	0.0571	CcSEcCtD
Epirubicin—Proctitis—Dactinomycin—ocular cancer	0.00184	0.0469	CcSEcCtD
Epirubicin—Extravasation—Carboplatin—ocular cancer	0.00139	0.0353	CcSEcCtD
Epirubicin—Multi-organ failure—Dactinomycin—ocular cancer	0.00138	0.0351	CcSEcCtD
Epirubicin—Phlebitis—Carboplatin—ocular cancer	0.00102	0.026	CcSEcCtD
Epirubicin—Ascites—Dactinomycin—ocular cancer	0.000988	0.0252	CcSEcCtD
Epirubicin—Ulcerative stomatitis—Dactinomycin—ocular cancer	0.000973	0.0248	CcSEcCtD
Epirubicin—Myelosuppression—Dactinomycin—ocular cancer	0.000958	0.0244	CcSEcCtD
Epirubicin—Febrile neutropenia—Dactinomycin—ocular cancer	0.000747	0.019	CcSEcCtD
Epirubicin—Eruption—Dactinomycin—ocular cancer	0.00073	0.0186	CcSEcCtD
Epirubicin—Folliculitis—Dactinomycin—ocular cancer	0.000715	0.0182	CcSEcCtD
Epirubicin—Hepatomegaly—Dactinomycin—ocular cancer	0.000635	0.0162	CcSEcCtD
Epirubicin—Necrosis—Dactinomycin—ocular cancer	0.000572	0.0146	CcSEcCtD
Epirubicin—Extravasation—Dactinomycin—ocular cancer	0.000515	0.0131	CcSEcCtD
Epirubicin—Hypocalcaemia—Dactinomycin—ocular cancer	0.000491	0.0125	CcSEcCtD
Epirubicin—Ulcer—Dactinomycin—ocular cancer	0.000475	0.0121	CcSEcCtD
Epirubicin—Infection—Carboplatin—ocular cancer	0.000429	0.0109	CcSEcCtD
Epirubicin—Aplastic anaemia—Dactinomycin—ocular cancer	0.000422	0.0107	CcSEcCtD
Epirubicin—Oesophagitis—Dactinomycin—ocular cancer	0.00041	0.0105	CcSEcCtD
Epirubicin—Mouth ulceration—Dactinomycin—ocular cancer	0.000406	0.0103	CcSEcCtD
Epirubicin—Sepsis—Dactinomycin—ocular cancer	0.00039	0.00993	CcSEcCtD
Epirubicin—Phlebitis—Dactinomycin—ocular cancer	0.000378	0.00964	CcSEcCtD
Epirubicin—Pain—Carboplatin—ocular cancer	0.000369	0.0094	CcSEcCtD
Epirubicin—Hepatic failure—Dactinomycin—ocular cancer	0.000363	0.00924	CcSEcCtD
Epirubicin—Body temperature increased—Carboplatin—ocular cancer	0.000341	0.00869	CcSEcCtD
Epirubicin—Lethargy—Dactinomycin—ocular cancer	0.000333	0.00848	CcSEcCtD
Epirubicin—Liver function test abnormal—Dactinomycin—ocular cancer	0.000301	0.00767	CcSEcCtD
Epirubicin—Toxic epidermal necrolysis—Dactinomycin—ocular cancer	0.000294	0.00748	CcSEcCtD
Epirubicin—Aspartate aminotransferase increased—Dactinomycin—ocular cancer	0.000294	0.00748	CcSEcCtD
Epirubicin—Dysphagia—Dactinomycin—ocular cancer	0.000282	0.00718	CcSEcCtD
Epirubicin—Pancytopenia—Dactinomycin—ocular cancer	0.000268	0.00682	CcSEcCtD
Epirubicin—Neutropenia—Dactinomycin—ocular cancer	0.000264	0.00671	CcSEcCtD
Epirubicin—Pneumonia—Dactinomycin—ocular cancer	0.000253	0.00644	CcSEcCtD
Epirubicin—Stevens-Johnson syndrome—Dactinomycin—ocular cancer	0.000249	0.00635	CcSEcCtD
Epirubicin—Stomatitis—Dactinomycin—ocular cancer	0.000245	0.00624	CcSEcCtD
Epirubicin—Agranulocytosis—Dactinomycin—ocular cancer	0.000234	0.00597	CcSEcCtD
Epirubicin—Hepatitis—Dactinomycin—ocular cancer	0.000226	0.00575	CcSEcCtD
Epirubicin—Pharyngitis—Dactinomycin—ocular cancer	0.000224	0.0057	CcSEcCtD
Epirubicin—Erythema multiforme—Dactinomycin—ocular cancer	0.000213	0.00543	CcSEcCtD
Epirubicin—Flushing—Dactinomycin—ocular cancer	0.000209	0.00533	CcSEcCtD
Epirubicin—Chills—Dactinomycin—ocular cancer	0.000202	0.00516	CcSEcCtD
Epirubicin—Alopecia—Dactinomycin—ocular cancer	0.000199	0.00508	CcSEcCtD
Epirubicin—Erythema—Dactinomycin—ocular cancer	0.000196	0.005	CcSEcCtD
Epirubicin—Ill-defined disorder—Dactinomycin—ocular cancer	0.000182	0.00464	CcSEcCtD
Epirubicin—Anaemia—Dactinomycin—ocular cancer	0.000181	0.00462	CcSEcCtD
Epirubicin—Malaise—Dactinomycin—ocular cancer	0.000177	0.00451	CcSEcCtD
Epirubicin—Leukopenia—Dactinomycin—ocular cancer	0.000176	0.00448	CcSEcCtD
Epirubicin—Myalgia—Dactinomycin—ocular cancer	0.000167	0.00426	CcSEcCtD
Epirubicin—Discomfort—Dactinomycin—ocular cancer	0.000165	0.00421	CcSEcCtD
Epirubicin—Oedema—Dactinomycin—ocular cancer	0.00016	0.00408	CcSEcCtD
Epirubicin—Infection—Dactinomycin—ocular cancer	0.000159	0.00406	CcSEcCtD
Epirubicin—Thrombocytopenia—Dactinomycin—ocular cancer	0.000157	0.004	CcSEcCtD
Epirubicin—Anorexia—Dactinomycin—ocular cancer	0.000153	0.00389	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Dactinomycin—ocular cancer	0.000146	0.00372	CcSEcCtD
Epirubicin—Decreased appetite—Dactinomycin—ocular cancer	0.000139	0.00355	CcSEcCtD
Epirubicin—Fatigue—Dactinomycin—ocular cancer	0.000138	0.00352	CcSEcCtD
Epirubicin—Pain—Dactinomycin—ocular cancer	0.000137	0.00349	CcSEcCtD
Epirubicin—Feeling abnormal—Dactinomycin—ocular cancer	0.000132	0.00336	CcSEcCtD
Epirubicin—Gastrointestinal pain—Dactinomycin—ocular cancer	0.000131	0.00334	CcSEcCtD
Epirubicin—Body temperature increased—Dactinomycin—ocular cancer	0.000127	0.00323	CcSEcCtD
Epirubicin—Abdominal pain—Dactinomycin—ocular cancer	0.000127	0.00323	CcSEcCtD
Epirubicin—TOP2A—Cell Cycle, Mitotic—RBL2—ocular cancer	0.000124	0.0013	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—MYBL2—ocular cancer	0.000123	0.00129	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—E2F4—ocular cancer	0.000123	0.00129	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—EP300—ocular cancer	0.000123	0.00129	CbGpPWpGaD
Epirubicin—PLA2G4A—p38 MAPK Signaling Pathway—HRAS—ocular cancer	0.000123	0.00129	CbGpPWpGaD
Epirubicin—TOP2A—Mitotic G1-G1/S phases—CDK2—ocular cancer	0.000123	0.00128	CbGpPWpGaD
Epirubicin—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—ocular cancer	0.000122	0.00128	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—E2F2—ocular cancer	0.000121	0.00127	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—RBL1—ocular cancer	0.000121	0.00127	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—GNA11—ocular cancer	0.00012	0.00126	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—CCND2—ocular cancer	0.000119	0.00125	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—HDAC1—ocular cancer	0.000119	0.00125	CbGpPWpGaD
Epirubicin—YWHAG—mTOR signaling pathway—HRAS—ocular cancer	0.000119	0.00125	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—EP300—ocular cancer	0.000119	0.00124	CbGpPWpGaD
Epirubicin—Hypersensitivity—Dactinomycin—ocular cancer	0.000118	0.00301	CcSEcCtD
Epirubicin—TOP2A—Cell Cycle, Mitotic—E2F3—ocular cancer	0.000117	0.00123	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—RBBP4—ocular cancer	0.000117	0.00123	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.000117	0.00123	CbGpPWpGaD
Epirubicin—TOP2A—Mitotic G1-G1/S phases—CDK4—ocular cancer	0.000116	0.00121	CbGpPWpGaD
Epirubicin—Asthenia—Dactinomycin—ocular cancer	0.000115	0.00293	CcSEcCtD
Epirubicin—YWHAG—G2/M Transition—EP300—ocular cancer	0.000113	0.00119	CbGpPWpGaD
Epirubicin—YWHAG—Translocation of GLUT4 to the plasma membrane—AKT1—ocular cancer	0.000112	0.00118	CbGpPWpGaD
Epirubicin—YWHAG—Mitotic G2-G2/M phases—EP300—ocular cancer	0.000112	0.00117	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—GNAQ—ocular cancer	0.000112	0.00117	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CDC25A—ocular cancer	0.000112	0.00117	CbGpPWpGaD
Epirubicin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—ocular cancer	0.000111	0.00117	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—RBL2—ocular cancer	0.000111	0.00116	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGF Pathway—HRAS—ocular cancer	0.00011	0.00116	CbGpPWpGaD
Epirubicin—Diarrhoea—Dactinomycin—ocular cancer	0.00011	0.00279	CcSEcCtD
Epirubicin—TOP2A—Cell Cycle, Mitotic—TFDP1—ocular cancer	0.000109	0.00114	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.000108	0.00113	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—CDKN2B—ocular cancer	0.000107	0.00112	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—TGFB1—ocular cancer	0.000107	0.00112	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—CCND2—ocular cancer	0.000107	0.00112	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—HDAC1—ocular cancer	0.000107	0.00112	CbGpPWpGaD
Epirubicin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—ocular cancer	0.000106	0.00111	CbGpPWpGaD
Epirubicin—YWHAG—mTOR signaling pathway—AKT1—ocular cancer	0.000105	0.00111	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—CDK6—ocular cancer	0.000105	0.0011	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—RBBP4—ocular cancer	0.000105	0.0011	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—E2F3—ocular cancer	0.000105	0.0011	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—MYC—ocular cancer	0.000103	0.00108	CbGpPWpGaD
Epirubicin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—ocular cancer	0.000103	0.00108	CbGpPWpGaD
Epirubicin—Vomiting—Dactinomycin—ocular cancer	0.000102	0.0026	CcSEcCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.000102	0.00107	CbGpPWpGaD
Epirubicin—Rash—Dactinomycin—ocular cancer	0.000101	0.00257	CcSEcCtD
Epirubicin—TOP2A—Mitotic G1-G1/S phases—RB1—ocular cancer	0.000101	0.00106	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CDC25A—ocular cancer	9.97e-05	0.00105	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CCND3—ocular cancer	9.88e-05	0.00104	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—E2F1—ocular cancer	9.83e-05	0.00103	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—TFDP1—ocular cancer	9.75e-05	0.00102	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—CDKN2B—ocular cancer	9.58e-05	0.001	CbGpPWpGaD
Epirubicin—Nausea—Dactinomycin—ocular cancer	9.52e-05	0.00243	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle—CDK6—ocular cancer	9.41e-05	0.000987	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	9.32e-05	0.000977	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	9.28e-05	0.000973	CbGpPWpGaD
Epirubicin—YWHAG—PDGFR-beta signaling pathway—MYC—ocular cancer	9.12e-05	0.000956	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—CCND2—ocular cancer	9.05e-05	0.000949	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—HDAC1—ocular cancer	9.05e-05	0.000949	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CCND3—ocular cancer	8.84e-05	0.000927	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—TP53—ocular cancer	8.81e-05	0.000924	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—E2F1—ocular cancer	8.79e-05	0.000922	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	8.77e-05	0.00092	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—EP300—ocular cancer	8.77e-05	0.000919	CbGpPWpGaD
Epirubicin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—ocular cancer	8.52e-05	0.000894	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—TP53—ocular cancer	8.5e-05	0.000891	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—CDK2—ocular cancer	8.48e-05	0.000889	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—CDK4—ocular cancer	8.42e-05	0.000883	CbGpPWpGaD
Epirubicin—YWHAG—ErbB1 downstream signaling—HRAS—ocular cancer	8.24e-05	0.000864	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PSPH—ocular cancer	8.15e-05	0.000854	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—CDKN2B—ocular cancer	8.12e-05	0.000851	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—CCND2—ocular cancer	8.1e-05	0.000849	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—HDAC1—ocular cancer	8.1e-05	0.000849	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	8.04e-05	0.000843	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—CDK4—ocular cancer	8.01e-05	0.00084	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PSPH—ocular cancer	7.99e-05	0.000838	CbGpPWpGaD
Epirubicin—TOP2A—Mitotic G1-G1/S phases—CDKN1B—ocular cancer	7.84e-05	0.000822	CbGpPWpGaD
Epirubicin—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—HRAS—ocular cancer	7.71e-05	0.000808	CbGpPWpGaD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—HRAS—ocular cancer	7.68e-05	0.000805	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	7.6e-05	0.000797	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—CDK2—ocular cancer	7.58e-05	0.000795	CbGpPWpGaD
Epirubicin—PLA2G4A—Endothelins—HRAS—ocular cancer	7.51e-05	0.000787	CbGpPWpGaD
Epirubicin—TOP2A—Mitotic G1-G1/S phases—CCND1—ocular cancer	7.48e-05	0.000784	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—E2F1—ocular cancer	7.45e-05	0.000781	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—GNA11—ocular cancer	7.43e-05	0.000779	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CDK6—ocular cancer	7.36e-05	0.000772	CbGpPWpGaD
Epirubicin—YWHAG—ErbB1 downstream signaling—AKT1—ocular cancer	7.27e-05	0.000762	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—CDKN2B—ocular cancer	7.26e-05	0.000761	CbGpPWpGaD
Epirubicin—TOP2A—Mitotic G1-G1/S phases—CDKN1A—ocular cancer	7.23e-05	0.000759	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—AKT1—ocular cancer	7.18e-05	0.000752	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—CDK4—ocular cancer	7.16e-05	0.000751	CbGpPWpGaD
Epirubicin—YWHAG—PDGFR-beta signaling pathway—HRAS—ocular cancer	7.16e-05	0.000751	CbGpPWpGaD
Epirubicin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—ocular cancer	7e-05	0.000734	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—RB1—ocular cancer	6.97e-05	0.000731	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—GNAQ—ocular cancer	6.91e-05	0.000724	CbGpPWpGaD
Epirubicin—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—AKT1—ocular cancer	6.8e-05	0.000713	CbGpPWpGaD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—AKT1—ocular cancer	6.78e-05	0.000711	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—E2F1—ocular cancer	6.66e-05	0.000698	CbGpPWpGaD
Epirubicin—PLA2G4A—Endothelins—AKT1—ocular cancer	6.63e-05	0.000695	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CDK6—ocular cancer	6.58e-05	0.00069	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	6.5e-05	0.000682	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—CDK2—ocular cancer	6.43e-05	0.000674	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—AKT1—ocular cancer	6.39e-05	0.00067	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PSPH—ocular cancer	6.38e-05	0.000669	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CCND2—ocular cancer	6.33e-05	0.000664	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—HDAC1—ocular cancer	6.33e-05	0.000664	CbGpPWpGaD
Epirubicin—YWHAG—Apoptosis—TP53—ocular cancer	6.31e-05	0.000661	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—RB1—ocular cancer	6.23e-05	0.000653	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—GNA11—ocular cancer	6.2e-05	0.00065	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—CDK4—ocular cancer	6.07e-05	0.000637	CbGpPWpGaD
Epirubicin—TOP2A—Mitotic G1-G1/S phases—MYC—ocular cancer	6e-05	0.000629	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	5.94e-05	0.000623	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—GNAQ—ocular cancer	5.77e-05	0.000605	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—CDK2—ocular cancer	5.75e-05	0.000602	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CDKN2B—ocular cancer	5.68e-05	0.000595	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	5.67e-05	0.000594	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CCND2—ocular cancer	5.66e-05	0.000594	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—HDAC1—ocular cancer	5.66e-05	0.000594	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	5.63e-05	0.000591	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—EP300—ocular cancer	5.57e-05	0.000584	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—MYC—ocular cancer	5.53e-05	0.000579	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	5.48e-05	0.000575	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—CDK4—ocular cancer	5.43e-05	0.000569	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—CDKN1B—ocular cancer	5.42e-05	0.000569	CbGpPWpGaD
Epirubicin—YWHAG—Apoptosis—AKT1—ocular cancer	5.33e-05	0.000558	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—MDM2—ocular cancer	5.31e-05	0.000557	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—RB1—ocular cancer	5.28e-05	0.000554	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	5.22e-05	0.000547	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—E2F1—ocular cancer	5.21e-05	0.000546	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—HDAC1—ocular cancer	5.2e-05	0.000545	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—CCND1—ocular cancer	5.17e-05	0.000543	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	5.14e-05	0.000539	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CDKN2B—ocular cancer	5.08e-05	0.000532	CbGpPWpGaD
Epirubicin—ABCC1—Disease—SAG—ocular cancer	5.05e-05	0.000529	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—EP300—ocular cancer	5.01e-05	0.000525	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—CDKN1A—ocular cancer	5.01e-05	0.000525	CbGpPWpGaD
Epirubicin—UGT2B7—NRF2 pathway—TGFB1—ocular cancer	4.96e-05	0.000521	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	4.91e-05	0.000515	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—CDKN1B—ocular cancer	4.85e-05	0.000509	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—EP300—ocular cancer	4.76e-05	0.000499	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	4.75e-05	0.000498	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—RB1—ocular cancer	4.72e-05	0.000495	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—E2F1—ocular cancer	4.66e-05	0.000488	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—CCND1—ocular cancer	4.63e-05	0.000485	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	4.54e-05	0.000476	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	4.53e-05	0.000475	CbGpPWpGaD
Epirubicin—YWHAG—Membrane Trafficking—AKT1—ocular cancer	4.52e-05	0.000474	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	4.52e-05	0.000474	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CDK2—ocular cancer	4.49e-05	0.000471	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—CDKN1A—ocular cancer	4.48e-05	0.000469	CbGpPWpGaD
Epirubicin—ABCC1—Disease—E2F5—ocular cancer	4.47e-05	0.000469	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SAG—ocular cancer	4.43e-05	0.000464	CbGpPWpGaD
Epirubicin—ABCC1—Disease—E2F4—ocular cancer	4.38e-05	0.000459	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—HRAS—ocular cancer	4.34e-05	0.000455	CbGpPWpGaD
Epirubicin—ABCC1—Disease—RBL1—ocular cancer	4.29e-05	0.00045	CbGpPWpGaD
Epirubicin—ABCC1—Disease—RPL39—ocular cancer	4.29e-05	0.00045	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—EP300—ocular cancer	4.26e-05	0.000447	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CDK4—ocular cancer	4.25e-05	0.000445	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—MYC—ocular cancer	4.15e-05	0.000435	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—CDKN1B—ocular cancer	4.11e-05	0.000431	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—MDM2—ocular cancer	4.03e-05	0.000422	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CDK2—ocular cancer	4.02e-05	0.000421	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	3.94e-05	0.000413	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	3.93e-05	0.000412	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—CCND1—ocular cancer	3.92e-05	0.000411	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—E2F5—ocular cancer	3.92e-05	0.000411	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—E2F4—ocular cancer	3.84e-05	0.000402	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CDK4—ocular cancer	3.8e-05	0.000398	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—CDKN1A—ocular cancer	3.79e-05	0.000398	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—RBL1—ocular cancer	3.76e-05	0.000395	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	3.73e-05	0.000391	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—MYC—ocular cancer	3.71e-05	0.000389	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—RB1—ocular cancer	3.69e-05	0.000387	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—CDK2—ocular cancer	3.69e-05	0.000387	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—CDKN1B—ocular cancer	3.68e-05	0.000385	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—EP300—ocular cancer	3.61e-05	0.000378	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—TP53—ocular cancer	3.58e-05	0.000376	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—GNA11—ocular cancer	3.56e-05	0.000373	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—CCND1—ocular cancer	3.51e-05	0.000368	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	3.49e-05	0.000366	CbGpPWpGaD
Epirubicin—ABCC1—Disease—TFDP1—ocular cancer	3.46e-05	0.000363	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—CDKN1A—ocular cancer	3.39e-05	0.000356	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—GNAQ—ocular cancer	3.31e-05	0.000347	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—RB1—ocular cancer	3.3e-05	0.000346	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—E2F3—ocular cancer	3.26e-05	0.000342	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	3.23e-05	0.000339	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—EP300—ocular cancer	3.23e-05	0.000338	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	3.15e-05	0.00033	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—MYC—ocular cancer	3.15e-05	0.00033	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—TP53—ocular cancer	3.05e-05	0.00032	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TFDP1—ocular cancer	3.03e-05	0.000318	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CDKN1B—ocular cancer	2.88e-05	0.000301	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—MDM2—ocular cancer	2.82e-05	0.000295	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—MYC—ocular cancer	2.81e-05	0.000295	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MAML2—ocular cancer	2.75e-05	0.000288	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CCND1—ocular cancer	2.74e-05	0.000288	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	2.73e-05	0.000286	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CDKN1A—ocular cancer	2.65e-05	0.000278	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CDKN1B—ocular cancer	2.57e-05	0.00027	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GNA11—ocular cancer	2.56e-05	0.000269	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—EP300—ocular cancer	2.52e-05	0.000265	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GNA11—ocular cancer	2.51e-05	0.000264	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—EP300—ocular cancer	2.48e-05	0.00026	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CCND1—ocular cancer	2.45e-05	0.000257	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—ocular cancer	2.43e-05	0.000255	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MAML2—ocular cancer	2.41e-05	0.000253	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GNAQ—ocular cancer	2.38e-05	0.00025	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CDKN1A—ocular cancer	2.37e-05	0.000249	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GNAQ—ocular cancer	2.34e-05	0.000245	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—TP53—ocular cancer	2.31e-05	0.000242	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—EP300—ocular cancer	2.26e-05	0.000237	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—MYC—ocular cancer	2.2e-05	0.000231	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—GNA11—ocular cancer	2.1e-05	0.00022	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—EP300—ocular cancer	2.07e-05	0.000217	CbGpPWpGaD
Epirubicin—ABCC1—Disease—HDAC1—ocular cancer	2.01e-05	0.000211	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GNA11—ocular cancer	2.01e-05	0.000211	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—MYC—ocular cancer	1.97e-05	0.000206	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—GNAQ—ocular cancer	1.95e-05	0.000205	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—EP300—ocular cancer	1.89e-05	0.000198	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GNAQ—ocular cancer	1.87e-05	0.000196	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CDKN2B—ocular cancer	1.8e-05	0.000189	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—TGFB1—ocular cancer	1.8e-05	0.000189	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HDAC1—ocular cancer	1.76e-05	0.000185	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—TP53—ocular cancer	1.62e-05	0.000169	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CDKN2B—ocular cancer	1.58e-05	0.000166	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	1.51e-05	0.000158	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—AKT1—ocular cancer	1.5e-05	0.000157	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—TP53—ocular cancer	1.48e-05	0.000155	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—E2F1—ocular cancer	1.45e-05	0.000152	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—HRAS—ocular cancer	1.42e-05	0.000149	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—AKT1—ocular cancer	1.25e-05	0.000131	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MDM2—ocular cancer	1e-05	0.000105	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CDKN1B—ocular cancer	9.13e-06	9.57e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MDM2—ocular cancer	8.76e-06	9.19e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—EP300—ocular cancer	8.57e-06	8.98e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CDKN1A—ocular cancer	8.42e-06	8.83e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—EP300—ocular cancer	8.4e-06	8.81e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—HRAS—ocular cancer	8.14e-06	8.53e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—EP300—ocular cancer	8.02e-06	8.4e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CDKN1B—ocular cancer	8e-06	8.39e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCND1—ocular cancer	7.63e-06	8e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CDKN1A—ocular cancer	7.38e-06	7.74e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—AKT1—ocular cancer	7.19e-06	7.53e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—EP300—ocular cancer	7.02e-06	7.37e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MYC—ocular cancer	6.98e-06	7.32e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—TGFB1—ocular cancer	6.97e-06	7.31e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—EP300—ocular cancer	6.71e-06	7.04e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MYC—ocular cancer	6.12e-06	6.42e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TGFB1—ocular cancer	6.11e-06	6.4e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—HRAS—ocular cancer	5.49e-06	5.75e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—AKT1—ocular cancer	5.18e-06	5.43e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—AKT1—ocular cancer	5.08e-06	5.32e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TP53—ocular cancer	5.03e-06	5.27e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—AKT1—ocular cancer	4.84e-06	5.08e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HRAS—ocular cancer	4.81e-06	5.04e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—AKT1—ocular cancer	4.25e-06	4.45e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—AKT1—ocular cancer	4.06e-06	4.25e-05	CbGpPWpGaD
